Clinical Trials Browser

Recruiting × Observational × Breast Adenocarcinoma × Clear all

NCT04517838 2025-12-24

Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

Breast Adenocarcinoma